Rockwell Medical Overview
- Year Founded
-
1996
- Status
-
Public
- Employees
-
157
- Stock Symbol
-
RMTI
- Investments
-
2
- Share Price
-
$7.03
- (As of Friday Closing)
Rockwell Medical General Information
Description
Rockwell Medical Inc is a healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products for dialysis providers. It is a supplier of liquid bicarbonate concentrates, acid, and dry bicarbonate concentrates for dialysis patients in the United States. The company's products include CitraPure citric acid concentrate, RenalPure liquid acid concentrate, and SteriLyte bicarbonate concentrate, among others. The company delivers the majority of its hemodialysis concentrates products and mixers to dialysis clinics throughout the United States and internationally, utilizing its own delivery trucks and third-party carriers.
Contact Information
Website
www.rockwellmed.comCorporate Office
- 30142 Wixom Road
- Wixom, MI 48393
- United States
Corporate Office
- 30142 Wixom Road
- Wixom, MI 48393
- United States
Rockwell Medical Stock Performance
As of 13-Nov-2026, Rockwell Medical’s stock price is $7.03. Its current market cap is $27.9M with 3.97M shares.
(As of Friday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $7.03 | $7.38 | $4.88 - $12.90 | $27.9M | 3.97M | 25K | -$1.43 |
Rockwell Medical Financials Summary
As of 30-Sep-2026, Rockwell Medical has a trailing 12-month revenue of $72.6M.
|
In Thousands, USD |
TTM 30-Sep-2026 | FY 2025 31-Dec-2025 | FY 2024 31-Dec-2024 | FY 2023 31-Dec-2023 |
|---|---|---|---|---|
| EV | 23,556 | 22,262 | 61,834 | 56,992 |
| Revenue | 72,584 | 69,258 | 101,489 | 83,612 |
| EBITDA | (2,597) | (2,232) | 2,862 | (4,905) |
| Net Income | (5,655) | (5,314) | (480) | (8,439) |
| Total Assets | 57,084 | 57,145 | 59,208 | 52,173 |
| Total Debt | 13,533 | 12,472 | 13,535 | 13,439 |
Rockwell Medical Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Rockwell Medical Comparisons
Industry
Financing
Details
Rockwell Medical Competitors (12)
One of Rockwell Medical’s 12 competitors is Grifols, a Corporation company based in Barcelona, Spain.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Grifols | Corporation | Barcelona, Spain | ||||
| Novartis | Corporation | Basel, Switzerland | ||||
| Nevian Lifescience | Corporate Backed or Acquired | Dhaka, Bangladesh | ||||
| Sanofi | Corporation | Gentilly, France | ||||
| Beloteca | Corporation | San Diego, CA |
Rockwell Medical Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Rockwell Medical Patents
Rockwell Medical Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| CA-3010771-A1 | Combination therapy with an iron compound and a citrate compound | Inactive | 06-Jan-2016 | ||
| EP-3399970-A1 | Composition therapy with an iron compound and a citrate compound | Inactive | 06-Jan-2016 | ||
| WO-2017120311-A1 | Composition therapy with an iron compound and a citrate compound | Inactive | 06-Jan-2016 | ||
| AU-2016315877-A1 | Solid soluble ferric pyrophosphate formulations, kits, and methods using the same | Active | 04-Sep-2015 | ||
| AU-2016315877-B2 | Solid soluble ferric pyrophosphate formulations, kits, and methods using the same | Inactive | 04-Sep-2015 | A61K9/1611 |
Rockwell Medical Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Rockwell Medical Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Rockwell Medical Investments & Acquisitions (2)
Rockwell Medical’s most recent deal was a Corporate Asset Purchase with Vantive (Portfolio of Hemodialysis Assets in Medola, Italy) for . The deal was made on 03-Nov-2026.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Vantive (Portfolio of Hemodialysis Assets in Medola, Italy) | 03-Nov-2026 | Corporate Asset Purchase | Buildings and Property | ||
| Evoqua Water Technologies (hemodialysis concentrates business) | 10-Jul-2023 | Merger/Acquisition | Commodity Chemicals |
Rockwell Medical ESG
Risk Overview
Risk Rating
Updated November, 04, 2026
38.71 | High Risk
Risk Scale
A lower score indicates better sustainability
Negl
0-10
Low
10-20
Med
20-30
High
30-40
Severe
40+
Exposure
Exposure refers to the extent to which a company is exposed to different material ESG issues
Management
Management is related to actions taken to manage ESG issues
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
of 13,585
Rank
Percentile
Pharmaceuticals
Industry
of 852
Rank
Percentile
Pharmaceuticals
Subindustry
of 354
Rank
Percentile
Rockwell Medical FAQs
-
When was Rockwell Medical founded?
Rockwell Medical was founded in 1996.
-
Where is Rockwell Medical headquartered?
Rockwell Medical is headquartered in Wixom, MI.
-
What is the size of Rockwell Medical?
Rockwell Medical has 157 total employees.
-
What industry is Rockwell Medical in?
Rockwell Medical’s primary industry is Pharmaceuticals.
-
Is Rockwell Medical a private or public company?
Rockwell Medical is a Public company.
-
What is Rockwell Medical’s stock symbol?
The ticker symbol for Rockwell Medical is RMTI.
-
What is the current stock price of Rockwell Medical?
As of 13-Nov-2026 the stock price of Rockwell Medical is $7.03.
-
What is the current market cap of Rockwell Medical?
The current market capitalization of Rockwell Medical is $27.9M.
-
What is Rockwell Medical’s current revenue?
The trailing twelve month revenue for Rockwell Medical is $72.6M.
-
Who are Rockwell Medical’s competitors?
Grifols, Novartis, Nevian Lifescience, Sanofi, and Beloteca are some of the 12 competitors of Rockwell Medical.
-
What is Rockwell Medical’s annual earnings per share (EPS)?
Rockwell Medical’s EPS for 12 months was -$1.43.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
